CIK 0000025743
- Non-accelerated filer
- Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870233535
- Phone
- +1 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 64 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-02-24 | Milligan John C.K. IV President | Sale | −8,300 | $6.23 | $52K | 6,334,718 |
| 2014-02-21 | Finizio Robert G CEO | Sale | −16,600 | $6.18 | $103K | 22,011,586 |
| 2014-02-20 | Finizio Robert G CEO | Sale | −16,700 | $6.17 | $103K | 22,028,186 |
| 2014-02-19 | Finizio Robert G CEO | Sale | −16,700 | $6.17 | $103K | 22,044,886 |
| 2014-02-12 | Bernick Brian Director | Sale | −15,625 | $6.05 | $95K | 7,457,267 |
| 2014-02-11 | Bernick Brian Director | Sale | −15,625 | $6.27 | $98K | 7,472,892 |
| 2014-02-10 | Krassan Mitchell EVP, Chief Strategy Officer | Exercise or conversion | +7,500 | $0.19 | $1K | 7,500 |
| 2014-02-10 | Krassan Mitchell EVP, Chief Strategy Officer | Sale | −7,500 | $6.34 | $48K | 0 |
| 2014-02-10 | Krassan Mitchell EVP, Chief Strategy Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −7,500 | 150,703 | ||
| 2014-01-30 | Milligan John C.K. IV President, Secretary | Sale | −8,400 | $6.49 | $55K | 6,343,018 |
| 2014-01-29 | Milligan John C.K. IV President, Secretary | Sale | −8,300 | $6.03 | $50K | 6,351,418 |
| 2014-01-28 | Milligan John C.K. IV President, Secretary | Sale | −8,300 | $5.94 | $49K | 6,359,718 |
| 2014-01-23 | Finizio Robert G CEO | Sale | −16,600 | $5.92 | $98K | 22,061,586 |
| 2014-01-22 | Finizio Robert G CEO | Sale | −16,700 | $5.66 | $95K | 22,078,186 |
| 2014-01-21 | Finizio Robert G CEO | Sale | −16,700 | $5.53 | $92K | 22,094,886 |
| 2014-01-13 | Krassan Mitchell EVP, Chief Strategy Officer | Exercise or conversion | +7,500 | $0.19 | $1K | 7,500 |
| 2014-01-13 | Krassan Mitchell EVP, Chief Strategy Officer | Sale | −7,500 | $5.73 | $43K | 0 |
| 2014-01-13 | Krassan Mitchell EVP, Chief Strategy Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −7,500 | 158,203 | ||
| 2014-01-08 | Bernick Brian Director | Sale | −15,625 | $5.21 | $81K | 7,488,517 |
| 2014-01-07 | Bernick Brian Director | Sale | −15,625 | $5.04 | $79K | 7,504,142 |
Page 31 of 33 · 642 trades